Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is one of the most common malignancies. Studies have shown that engulfment and cell motility 3 (ELMO3) is highly expressed in NSCLC and can be used as a novel biomarker, but its underlying mechanism remains to be explored. The aim of this study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Cailong, Zhang, Yong, Meng, Qinghai, Dai, Guoliang, Jiang, Zhitao, Bao, Hongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515945/
https://www.ncbi.nlm.nih.gov/pubmed/31134158
http://dx.doi.org/10.3389/fonc.2019.00363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515945/
https://www.ncbi.nlm.nih.gov/pubmed/31134158
http://dx.doi.org/10.3389/fonc.2019.00363

Ejemplares similares